Pall Introduces New Technologies at ACHEMA 2006

Pall Introduces Breakthrough Environmental
Air Monitoring Technology to Global Market

East Hills, NY (May 15, 2006) - - The need for faster, more reliable environmental air monitoring is becoming increasingly critical as the number of new drug therapies requiring production in controlled environments continues to rise. Current monitoring technologies do not readily distinguish externally introduced sampling contamination from microbial contaminants captured from the clean room air systems.  This can cause delays in microbiological analysis due to “false positives”, resulting in loss of both time and money. To resolve this problem, Pall Corporation (NYSE: PLL) is bringing its Ascotec™ environmental air monitoring systems to the global market so that biopharmaceutical companies can increase the predictability and accuracy of microbial samples, for the highest level of speed, safety and reliability.

 

New Environmentally Friendly Chromatography Sorbents from Pall
Improve Efficiency and Economics of Drug Manufacturing

East Hills, NY (May 15, 2006) - - More than 50 percent of biopharmaceutical companies are adversely affected by manufacturing bottlenecks due to capacity and production purification problems.  Compounding this challenge is the increasingly global demand for new protein-based drugs.  To help overcome these production bottlenecks, Pall Corporation (NYSE: PLL) is launching two new chromatography sorbents that provide a novel approach to protein purification.

 

Bench-top Chromatography System Speeds Process
Development of New Drugs

East Hills, NY (May 15, 2006) - - Cell separation and protein purification sequences in the laboratory are critical components of process development for new therapies requiring multiple steps that are often labor-intensive and time-consuming.  Pall Corporation (NYSE: PLL) is introducing a new bench-top system that automates the process, significantly improving laboratory efficiency and cutting down drug development time by weeks or even months.  The new PKL Chromatography System automates laboratory chromatography, the scientific methodology of separating biologics, enabling operations on a 24-hour continuous basis.  This flexible laboratory tool performs process optimization for new drugs used in clinical trials and small-scale production.  In addition to improving productivity, it also provides a roadmap for easy drug production scale-up.